Inhibitory effect of clotrimazole on angiogenesis associated with bladder epithelium proliferation in rats

International Journal of Urology

Volumn 10, Issue 2, 2003, Pages 78-85

  Takei, Shunsaku ^a,c   Iseda, Tokuhiro ^b   Yokoyama, Masayoshi ^b  

^a Matsuyama Nat Hosp   (Japan)

^b EHIME UNIVERSITY   (Japan)

^c Saiseikai Matsuyama Hospital   (Japan)

Author keywords

Clotrimazole; FLT1; Rat; Urinary bladder carcinogenesis; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; CLOTRIMAZOLE; DRINKING WATER; MESSENGER RNA; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR FLT1;

ANGIOGENESIS; ARTICLE; BLADDER CARCINOGENESIS; BLADDER EPITHELIUM; CAPILLARY; CELL PROLIFERATION; EARLY DIAGNOSIS; FEMALE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ANIMALS; BASE SEQUENCE; BUTYLHYDROXYBUTYLNITROSAMINE; CELL DIVISION; CLOTRIMAZOLE; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; EPITHELIUM; FEMALE; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037304912     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2003.00575.x     Document Type: Article

References (16)

1. Wakui S, Furusato M, Sakai S et al. Expression of vascular endothelial growth factor in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis. Vet. Pathol. 1999; 36: 111-6.
2. Takahashi H, Abe M, Sugawara T et al. Clotrimazole, an imidazole antimycotic, is a potent inhibitor of angiogenesis. Jpn. J. Cancer Res. 1998; 89: 445-51.
3. Kim NH, Jung HH, Cha DR, Choi DS. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. J. Endocrinol. 2000; 165: 617-24.
4. Okajima E, Ozono S. Experimental bladder tumor. Jpn. J. Urol. 1991; 82: 705-15.
5. Okajima E, Ozono S, Endo T et al. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl) nitrosamine treatment. Jpn. J. Cancer Res. 1997; 88: 543-52.
6. Fidler IJ, Singh RK, Yoneda J et al. Critical determinants of neoplastic angiogenesis. Cancer J. 2000; 6 (Suppl 3): S225-36.
7. Masuko T, Sugahara K, Nakajima S, Hashimoto Y. Altered expression of immunohistochemically detected cytochrome P-450 component (s) in nitrosamine-induced rat urinary bladder lesion. Jpn. J. Cancer Res. 1987; 78: 840-5.
8. Berg D, Regel E, Harenberg HE, Plempel M. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole. Arzneim.-Forsch 1984; 34: 139-46.
9. Yatsunami J, Tsuruta N, Wakamatsu K, Hara N, Hayashi S. Clarithromycin is a potent inhibitor of tumor-induced angiogenesis. Res. Exp. Med. (Berl.) 1997; 197: 189-97.
10. Sgadari C, Barillari G, Toschi E et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat. Med. 2002; 8: 225-32.
11. Buchel KH, Draber W, Regal E, Plempel M. Synthesen und Eigenschaften von Clotrimazol und weiteren anti-mykotischen 1-Triphenylmethylimidazolen. Arzneim.-Forsch 1972; 22: 1260-72.
12. Hoogerheide JG, Strusiak SH, Taddei CR, Townley ER, Wyka BE. High performance liquid chromatographic determination of clotrimazole in pharmaceutical formulations. J. Assoc. Off. Anal. Chem. 1981; 64: 864-9.
13. Benzaquen LR, Brugnara C, Byers HR, Gatton-Celli S, Halperin JA. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat. Med. 1995; 1: 534-40.
14. Alvarez J, Montero M, Garcia-Sancho J. High affinity inhibition of Ca (2+) -dependent K+ channels by cytochrome P-450 inhibitors. J. Biol. Chem. 1992; 267: 11789-93.
15. Tettenborn D. Acute toxicity and local tolerance of clotrimazole. Summery of test results. Arzneim.-Forsch 1972; 22: 1272-6.
16. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. USA 1994; 91: 4082-5.